R52.1 R52.2
Conditions
Interventions
Group 1: Patients with moderate chronic pain (NRS>=3) (minimum age 18 years) are examined in this study using quantitative sensory testing (QST) and bedside sensory testing. In addition, several quest
Sponsors
UKSH Universitätsklinikum Schleswig-Holstein. Neurologische Schmerzforschung und -therapie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: -Patients suffer from at least moderate chronic pain (NRS>=3) - Minimum age 18 years - Ability to give consent
Exclusion criteria
Exclusion criteria: -Major depression - Chronic alcohol abuse (regular consumption of alcohol that exceeds 10 g per day for women and 20 g per day for men) -Chronic substance abuse. Includes any illicit drugs and prescription medications such as opioids or benzodiazepines not prescribed to the patient or used in excessive doses -The use of medicinal cannabis or medicinal CBD or THC preparations, as well as the consumption of CBD preparations that fall under the Dietary Supplement Ordinance under German law is permitted. -Patients who use cannabis without a doctor's prescription or who do not obtain it from a pharmacy or licensed dispensary will be excluded from the study. -Patients who are currently participating in drug studies -Any reason that prevents an adequate understanding of the investigations carried out
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Validation of the painPREDICT in direct comparison with (a) the QST and (b) the bedside sensory test | — |
Secondary
| Measure | Time frame |
|---|---|
| -Enables the combination of painPREDICT and bedside sensory testing to better classify patients into sensory profiles. -Finally, the painPREDICT should be assessed for sensitivity to changes. | — |
Countries
Germany
Contacts
Public ContactRalf Baron
UKSH. Sektion Neurologische Schmerzforschung und -therapie
Outcome results
None listed